Paris, France

Alain Rousseau

This inventor holds 39 USPTO granted patents and 4 published patent applications, plus 10 CIPO patents and 15 EPO patents, primarily in In Vitro Diagnostics. Top assignees: Diagnostica Stago, Arteion, Roquette Freres. Active years: 1980-2025.

USPTO Granted Patents = 39 

% Patents Active = 84.6

 

 

Average Co-Inventor Count = 1.8

ph-index = 12

Forward Citations = 362(Granted Patents)


Location History:

  • Charenton le Pont, FR (1996)
  • Francaise, FR (2000)
  • 34000 Montpellier, FR (2006)
  • Paris, FR (1980 - 2024)
  • Saint Priest, FR (2015 - 2024)

Company Filing History:


Years Active: 1980-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Biological Sample Analysis
Flow Cytometry
Automatic Analyzers
Liquid Sample Analysis
Coagulation Time Detection
High-Viscosity Polyester
Polyurethane Coating
Optical Fiber
Microorganism Detection
Pipetting Device
Reagent Flask Seal
Fluid Flow Measurement
39 patents (USPTO):Explore Patents

Title: Alain Rousseau - Innovative Inventor from Paris

Introduction: Alain Rousseau is a renowned inventor based in Paris, France, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Alain Rousseau holds several patents in the areas of renewable energy, artificial intelligence, and medical devices, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a career spanning over two decades, Alain Rousseau has worked with leading research institutions and companies to develop cutting-edge solutions that have revolutionized industries worldwide.

Collaborations: Throughout his career, Alain Rousseau has collaborated with top universities, multinational corporations, and fellow inventors to bring his ideas to life and make a lasting impact on society.

Conclusion: Alain Rousseau's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…